High-resolution solution structure of basic fibroblast growth factor determined by multidimensional heteronuclear magnetic resonance spectroscopy - PubMed (original) (raw)
. 1996 Oct 22;35(42):13552-61.
doi: 10.1021/bi961260p.
Affiliations
- PMID: 8885834
- DOI: 10.1021/bi961260p
High-resolution solution structure of basic fibroblast growth factor determined by multidimensional heteronuclear magnetic resonance spectroscopy
F J Moy et al. Biochemistry. 1996.
Abstract
The high-resolution solution structure of recombinant human basic fibroblast growth factor (FGF-2), a protein of 17.2 kDa that exhibits a variety of functions related to cell growth and differentiation, has been determined using three-dimensional heteronuclear NMR spectroscopy. A total of 30 structures were calculated by means of hybrid distance geometry--simulated annealing using a total of 2865 experimental NMR restraints, consisting of 2486 approximate inteproton distance restraints, 50 distance restraints for 25 backbone hydrogen bonds, and 329 torsion angle restraints. The atomic rms distribution about the mean coordinate positions for the 30 structures for residues 29-152 is 0.43 +/- 0.03 A for the backbone atoms, 0.83 +/- 0.05 A for all atoms, and 0.51 +/- 0.04 A for all atoms excluding disordered side chains. The overall structure of FGF-2 consists of 11 extended antiparallel beta-strands arranged in three groups of three or four strands connected by tight turns and loop regions creating a pseudo-3-fold symmetry. Two strands from each group come together to form a beta-sheet barrel of six antiparallel beta-strands. A helix-like structure was observed for residues 131-136, which is part of the heparin binding site (residues 128-138). The discovery of the helix-like region in the primary heparin binding site instead of the beta-strand conformation described in the X-ray structures may have important implications in understanding the nature of heparin--FGF-2 interactions. A total of seven tightly bound water molecules were found in the FGF-2 structure, two of which are located in the heparin binding site. The first 28 N-terminal residues appear to be disordered, which is consistent with previous X-ray structures. A best fit superposition of the NMR structure of FGF-2 with the 1.9 A resolution X-ray structure by Zhu et al. (1991) yields a backbone atomic rms difference of 0.94 A, indicative of a close similarity between the NMR and X-ray structures.
Similar articles
- High-resolution solution structure of the inhibitor-free catalytic fragment of human fibroblast collagenase determined by multidimensional NMR.
Moy FJ, Chanda PK, Cosmi S, Pisano MR, Urbano C, Wilhelm J, Powers R. Moy FJ, et al. Biochemistry. 1998 Feb 10;37(6):1495-504. doi: 10.1021/bi972181w. Biochemistry. 1998. PMID: 9484219 - The solution structure of melanoma growth stimulating activity.
Fairbrother WJ, Reilly D, Colby TJ, Hesselgesser J, Horuk R. Fairbrother WJ, et al. J Mol Biol. 1994 Sep 23;242(3):252-70. doi: 10.1006/jmbi.1994.1577. J Mol Biol. 1994. PMID: 8089846 - High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor.
Moy FJ, Chanda PK, Chen JM, Cosmi S, Edris W, Levin JI, Powers R. Moy FJ, et al. J Mol Biol. 2000 Sep 22;302(3):671-89. doi: 10.1006/jmbi.2000.4082. J Mol Biol. 2000. PMID: 10986126 - Functional implications of interleukin-1 beta based on the three-dimensional structure.
Veerapandian B, Gilliland GL, Raag R, Svensson AL, Masui Y, Hirai Y, Poulos TL. Veerapandian B, et al. Proteins. 1992 Jan;12(1):10-23. doi: 10.1002/prot.340120103. Proteins. 1992. PMID: 1553379 Review. - Determining the structures of large proteins and protein complexes by NMR.
Clore GM, Gronenborn AM. Clore GM, et al. Trends Biotechnol. 1998 Jan;16(1):22-34. doi: 10.1016/S0167-7799(97)01135-9. Trends Biotechnol. 1998. PMID: 9470228 Review.
Cited by
- Structural and biochemical investigation into stable FGF2 mutants with novel mutation sites and hydrophobic replacements for surface-exposed cysteines.
An YJ, Jung YE, Lee KW, Kaushal P, Ko IY, Shin SM, Ji S, Yu W, Lee C, Lee WK, Cha K, Lee JH, Cha SS, Yim HS. An YJ, et al. PLoS One. 2024 Sep 5;19(9):e0307499. doi: 10.1371/journal.pone.0307499. eCollection 2024. PLoS One. 2024. PMID: 39236042 Free PMC article. - Fibroblast growth factor 2.
Nickle A, Ko S, Merrill AE. Nickle A, et al. Differentiation. 2024 Sep-Oct;139:100733. doi: 10.1016/j.diff.2023.10.001. Epub 2023 Oct 12. Differentiation. 2024. PMID: 37858405 Review. - Inhibition of FGFR Signaling by Targeting FGF/FGFR Extracellular Interactions: Towards the Comprehension of the Molecular Mechanism through NMR Approaches.
Pagano K, Longhi E, Molinari H, Taraboletti G, Ragona L. Pagano K, et al. Int J Mol Sci. 2022 Sep 17;23(18):10860. doi: 10.3390/ijms231810860. Int J Mol Sci. 2022. PMID: 36142770 Free PMC article. - Key steps in unconventional secretion of fibroblast growth factor 2 reconstituted with purified components.
Steringer JP, Lange S, Čujová S, Šachl R, Poojari C, Lolicato F, Beutel O, Müller HM, Unger S, Coskun Ü, Honigmann A, Vattulainen I, Hof M, Freund C, Nickel W. Steringer JP, et al. Elife. 2017 Jul 19;6:e28985. doi: 10.7554/eLife.28985. Elife. 2017. PMID: 28722655 Free PMC article. - Dimerization capacities of FGF2 purified with or without heparin-affinity chromatography.
Platonova N, Miquel G, Chiu LY, Taouji S, Moroni E, Colombo G, Chevet E, Sue SC, Bikfalvi A. Platonova N, et al. PLoS One. 2014 Oct 9;9(10):e110055. doi: 10.1371/journal.pone.0110055. eCollection 2014. PLoS One. 2014. PMID: 25299071 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases